Antiobesity Global Market Report 2025

Antiobesity Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antiobesity market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for antiobesity ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antiobesity market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Drug Class: Peripherally Acting Anti-Obesity Drugs; Centrally Acting Anti-Obesity Drugs

2) By Type: Prescription Drugs (Rx); OTC Drugs

3) By Medication: Monotherapies; Polytherapies

Subsegments:

1) By Peripherally Acting Anti-Obesity Drugs: Orlistat; Lorcaserin

2) By Centrally Acting Anti-Obesity Drugs: Phentermine; Topiramate; Naltrexone-Bupropion Combination; Liraglutide

Companies Mentioned: F. Hoffmann-La Roche AG; GlaxoSmithKline plc; Boehringer Ingelheim GmbH; Pfizer Inc.; Merck & Co. Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Antiobesity Market Characteristics
3. Antiobesity Market Trends And Strategies
4. Antiobesity Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Antiobesity Growth Analysis And Strategic Analysis Framework
5.1. Global Antiobesity PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Antiobesity Market Growth Rate Analysis
5.4. Global Antiobesity Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Antiobesity Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Antiobesity Total Addressable Market (TAM)
6. Antiobesity Market Segmentation
6.1. Global Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Peripherally Acting Anti-Obesity Drugs
Centrally Acting Anti-Obesity Drugs
6.2. Global Antiobesity Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prescription Drugs (Rx)
OTC Drugs
6.3. Global Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monotherapies
Polytherapies
6.4. Global Antiobesity Market, Sub-Segmentation Of Peripherally Acting Anti-Obesity Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Orlistat
Lorcaserin
6.5. Global Antiobesity Market, Sub-Segmentation Of Centrally Acting Anti-Obesity Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Phentermine
Topiramate
Naltrexone-Bupropion Combination
Liraglutide
7. Antiobesity Market Regional And Country Analysis
7.1. Global Antiobesity Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Antiobesity Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Antiobesity Market
8.1. Asia-Pacific Antiobesity Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Antiobesity Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Antiobesity Market
9.1. China Antiobesity Market Overview
9.2. China Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Antiobesity Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Antiobesity Market
10.1. India Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Antiobesity Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Antiobesity Market
11.1. Japan Antiobesity Market Overview
11.2. Japan Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Antiobesity Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Antiobesity Market
12.1. Australia Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Antiobesity Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Antiobesity Market
13.1. Indonesia Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Antiobesity Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Antiobesity Market
14.1. South Korea Antiobesity Market Overview
14.2. South Korea Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Antiobesity Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Antiobesity Market
15.1. Western Europe Antiobesity Market Overview
15.2. Western Europe Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Antiobesity Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Antiobesity Market
16.1. UK Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Antiobesity Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Antiobesity Market
17.1. Germany Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Antiobesity Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Antiobesity Market
18.1. France Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Antiobesity Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Antiobesity Market
19.1. Italy Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Antiobesity Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Antiobesity Market
20.1. Spain Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Antiobesity Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Antiobesity Market
21.1. Eastern Europe Antiobesity Market Overview
21.2. Eastern Europe Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Antiobesity Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Antiobesity Market
22.1. Russia Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Antiobesity Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Antiobesity Market
23.1. North America Antiobesity Market Overview
23.2. North America Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Antiobesity Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Antiobesity Market
24.1. USA Antiobesity Market Overview
24.2. USA Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Antiobesity Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Antiobesity Market
25.1. Canada Antiobesity Market Overview
25.2. Canada Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Antiobesity Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Antiobesity Market
26.1. South America Antiobesity Market Overview
26.2. South America Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Antiobesity Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Antiobesity Market
27.1. Brazil Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Antiobesity Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Antiobesity Market
28.1. Middle East Antiobesity Market Overview
28.2. Middle East Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Antiobesity Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Antiobesity Market
29.1. Africa Antiobesity Market Overview
29.2. Africa Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Antiobesity Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Antiobesity Market Competitive Landscape And Company Profiles
30.1. Antiobesity Market Competitive Landscape
30.2. Antiobesity Market Company Profiles
30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
30.2.2. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Antiobesity Market Other Major And Innovative Companies
31.1. Takeda Pharmaceutical Company Limited
31.2. Eisai Co. Ltd.
31.3. Novo Nordisk A/S
31.4. Zafgen Inc.
31.5. Rhythm Pharmaceuticals Inc.
31.6. Zydus Cadila
31.7. Norgine B.V.
31.8. Vivus Inc.
31.9. Arena Pharmaceuticals Inc.
31.10. Orexigen Therapeutics Inc.
31.11. Eli Lilly and Company
31.12. Amgen Inc.
31.13. AstraZeneca PLC
31.14. Novartis International AG
31.15. Viking Therapeutics Inc.
32. Global Antiobesity Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Antiobesity Market
34. Recent Developments In The Antiobesity Market
35. Antiobesity Market High Potential Countries, Segments and Strategies
35.1 Antiobesity Market In 2029 - Countries Offering Most New Opportunities
35.2 Antiobesity Market In 2029 - Segments Offering Most New Opportunities
35.3 Antiobesity Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings